TrialCancer prevention research (Philadelphia, Pa.)2016

Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety.

Margaret E Gatti-Mays et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.